Drug Approval | August 28, 2023
Lupin receives approval from USFDA for Pirfenidone Tablets
This product will be manufactured at Lupin's Pithampur facility in India
This product will be manufactured at Lupin's Pithampur facility in India
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
Subscribe To Our Newsletter & Stay Updated
